Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant

The National Institutes of Health seeks proposals for a Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls Subject Matter Expert consultant. The National Institute on Drug Abuse requires expertise advising on biologics development processes for programs including the National Institute of Neurological Disorders and Stroke Ultra-Rare Gene Therapy program and NIH Blueprint Neurotherapeutics Biologics program. Proposals will be evaluated on personnel qualifications, technical approach, and communication skills, with the highest rated offerors advancing to oral presentations. Quotes are due by August 7, 2023 for the base period of September 15, 2023 to September 14, 2024.

The solicitation has no set-aside designations and is conducted using full and open competition. The NAICS code is 541715 and PSC code R425. Evaluation will follow a two-phase process assessing qualifications, price, and past performance initially, then further evaluating technical approach and presentation skills. The labor-hour contract has a not to exceed amount of 600 hours annually valued at $1,200,000 over three years. Performance will take place at the contractor's site with communication by conference call and email.